[Physiopathology of pregnancy-induced hypertension].
Even though multiple factors are involved in arterial blood pressure elevation, during pregnancy-induced hypertension normal physiologic processes are occurring in the uteroplacental unit. These appear probably very early in pregnancy. Treatment of pregnancy-induced hypertension at the present time is directed simply at lowering the blood pressure. It should be emphasized that only one placebo-controlled study has demonstrated a beneficial effect of antihypertensive treatment for the fetus in moderate pregnancy-induced hypertension. Future treatment very likely will be preventive, administered from the onset of pregnancy in a high-risk patient.
D002395:Catecholamines / Q000097:blood; D015232:Dinoprostone; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011458:Prostaglandins E / Q000097:blood; D012084:Renin-Angiotensin System; D014655:Vascular Resistance
D002395:Catecholamines; D011458:Prostaglandins E; D004299:Dopamine beta-Hydroxylase; D015232:Dinoprostone
Physiopathologie de l'hypertension gravidique.